Replies to post #100377 on NanoViricides Inc. (NNVC)

[NanoEngineer]

NNVC has been repeating for months that they are currently producing the Cides for the tox. And now we learn in the 10-K that they have only produced 200g of FluCides which is a ridiculous quantity compared to the kilograms that they have said are required for tox because the Cides have no toxocity at all!

Look at what say said in a PR many months ago:

The Company has already successfully scaled up the synthesis to multi-gram scale, sufficient for animal testing, and can easily scale the processes to make kilogram quantities for widespread application in human patients if they are found to be effective and safe.

This statement combined with the reality described in the 10K proves that NNVC is lying to investors.

Furthermore, it shows that even if tox starts this week with the 200g of Flucide they have, tox won't be finished before 12 or 18 months since they need kilograms of Flucide to complete the tox.

Given this dull prospect, don't expect the completion of a Phase 2 clinical trial before 2018 at the earliest. Since the completion of a Phase 2 is a requirement to move sustainably the share price of a small biotech, NNVC stock will be a dead stock for years to come.

Delays, dilutions and even more delays seems to be the only reliable promises from NNVC.